BackInozyme Pharma Overview

Inozyme Pharma Other Assets

Track Inozyme Pharma's other assets ($0) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Other Assets
$0.00

Peer trimmed avg / median

Loading

Inozyme Pharma Other Assets History

Loading

Inozyme Pharma vs. peers: Other Assets Comparison

Loading

Inozyme Pharma Other Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Inozyme Pharma (INZY) FAQ

Inozyme Pharma (INZY) currently reports a other assets of $0 as of March 2025. In the prior-year period, the figure was $0. Use the charts on this page to explore Inozyme Pharma's other assets history and peer comparisons.

Inozyme Pharma's other assets changed from $0 to $0 (period ending March 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Inozyme Pharma reported $0 in other assets as of March 2025. In the prior-year period, the figure was $0. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other assets of $0, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Inozyme Pharma, and consider following INZY for alerts when major investors trade the stock.

Inozyme Pharma is classified in the Healthcare sector. On other assets, it currently shows $0. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing INZY with unrelated industries.